Selank Amidate · Research brief

Semax vs Selank for Memory, Anxiety and Mood

Real Peptides Research TeamEditorial

Updated September 21, 20269 min read

50 WORDS

Short answer

Neither peptide was designed as a brain supplement. Semax is a synthetic analog of ACTH(4-10), a fragment of adrenocorticotropic hormone stripped of its hormonal signalling. Selank is an analog of tuftsin, a four-residue immune peptide. Both earned their reputations afterwards, inside Russian clinical research, not on a nootropic drawing board.

Key takeaways

Semax is an ACTH(4-10) analog with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, while Selank is a tuftsin analog with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro.
On semax vs selank for memory endpoints, Semax carries most of the cognition and attention literature, largely through reported BDNF and TrkB upregulation.
Selank's research record centres on anxiolytic effects reported without sedation, muscle relaxation or withdrawal.
Both peptides share a Pro-Gly-Pro tail that is biologically active in its own right, which confounds head-to-head interpretation unless controlled for.
Neither compound is FDA-approved, and the strongest clinical literature for both comes from Russian research that Western trials have not replicated.
Lyophilized peptide holds at -20°C and reconstituted solution at 2 to 8°C, with freeze-thaw cycling the most common cause of silent potency loss.

We ship both compounds to research groups constantly, and the same question lands in our inbox every week: which one belongs in the memory protocol, and which one belongs in the anxiety model? The honest answer starts with their chemistry, not their marketing.

Semax vs Selank for memory: which peptide does the research literature link to cognition?

In the published record, semax vs selank for memory divides fairly cleanly. Semax carries the bulk of cognition, attention and neurotrophic data, largely tied to BDNF signalling. Selank's literature is dominated by anxiolytic and stress-adaptation endpoints. Both remain research-use-only peptides with no FDA approval for any indication.

The lazy version of this comparison says Semax is the focus one and Selank is the calm one. Directionally fine, mechanistically sloppy. The two share an identical Pro-Gly-Pro tail and overlap on enkephalin and monoamine pathways, which muddies any clean split. What follows covers their structural origins, what the literature reports across memory, anxiety, ADHD, mood, sleep and energy endpoints, and exactly where that evidence base runs thin.

Two molecules with completely different parents

Semax and Selank are both synthetic heptapeptides, both seven amino acids long, and both emerged from the Institute of Molecular Genetics at the Russian Academy of Sciences. That is roughly where the similarity ends.

Semax has the sequence Met-Glu-His-Phe-Pro-Gly-Pro and a molecular weight near 814 g/mol. It derives from ACTH(4-10), the melanocortin fragment, and retains that fragment's behavioural and neurotrophic activity without the corticotropic effect, so it doesn't drive cortisol release. Rodent work reports upregulation of BDNF (brain-derived neurotrophic factor) and its TrkB receptor in the hippocampus and cortex, along with modulation of dopaminergic and serotonergic transmission and shifts in gene expression tied to neuroinflammation and vascular tone in ischemia models. That neurotrophic angle is why Semax sits in cognition research.

Selank has the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro and a molecular weight near 752 g/mol. It derives from tuftsin, an endogenous immunomodulatory tetrapeptide. Its reported activity clusters around GABAergic signalling, serotonin turnover, and cytokine expression including interleukin-6 and interferon-related genes. The immune parentage isn't trivia. It's the reason Selank research keeps circling back to stress physiology and inflammatory tone rather than to learning curves.

Our team has watched this one distinction, melanocortin parent versus tuftsin parent, predict almost everything researchers find when they go read the primary sources themselves.

The shared tail that makes the comparison messier than it looks

Both peptides terminate in the same three residues: Pro-Gly-Pro. That tripeptide wasn't decoration. It was attached to slow enzymatic degradation, because the parent fragments, ACTH(4-10) and tuftsin, are cleaved by plasma and brain peptidases almost immediately.

Here is the part most comparisons skip entirely. Pro-Gly-Pro is itself a biologically active glyproline, studied independently for gastroprotective, antithrombotic and neuroprotective properties. Both compounds degrade toward it. So when a rodent study shows overlapping outcomes across Semax and Selank arms, some of that overlap may reflect a shared metabolite rather than a shared primary mechanism. A semax vs selank for memory experiment designed without a Pro-Gly-Pro control arm builds in a confound from the first day.

Stability shapes the literature too. Both peptides are short-lived in plasma, which is why the Russian clinical work leaned so heavily on intranasal delivery, and why modified analogs exist at all. Acetylated and amidated versions such as Semax amidate and Selank amidate were developed specifically to resist aminopeptidase cleavage and extend residence time.

Lab handling follows the same logic. Lyophilized powder holds at -20°C, reconstituted solution sits at 2 to 8°C, and repeated freeze-thaw cycles degrade peptide integrity without changing anything you can see in the vial.

What the research reports, endpoint by endpoint

Does Semax or Selank help with anxiety? The anxiolytic signal sits overwhelmingly with Selank. Russian clinical reports describe it in generalized anxiety and adjustment-type presentations, sometimes benchmarked against benzodiazepines, with the recurring observation that it produced anxiolysis without sedation, muscle relaxation or withdrawal phenomena. Those studies were small, mostly domestic, and have not been replicated under Western regulatory standards.

On memory and studying-related endpoints, Semax dominates. Rodent passive-avoidance and maze work reports improved retention, and Russian human research has focused on attention, working memory and recovery after cerebral ischemia. Anyone comparing semax vs selank for memory in a study design will find far more cognition literature on the Semax side.

On attention regulation, Russian paediatric literature describes Semax in attention deficit and minimal brain dysfunction contexts; Selank appears mostly in asthenic and anxious-asthenic states. No Western randomized controlled trials exist for either in ADHD, so the honest position is that evidence is preliminary and geographically narrow. For depression, neither compound is an antidepressant. Selank's serotonergic effects and Semax's BDNF angle have been explored as adjuncts in asthenic-depressive presentations, nothing more.

Sleep research suggests any benefit from Selank is secondary to reduced anxiety rather than a direct hypnotic action, while Semax is consistently characterized as activating rather than calming, which is also why researchers investigating energy and drive endpoints gravitate toward Semax and toward the mitochondrial energy collection for adjacent work.

These are research-use-only compounds, not approved for human or veterinary use, and anyone weighing an animal-model design should talk to their veterinarian first. Everything here is educational summary of published research, not guidance for use in any person.

Semax vs Selank for Memory, Anxiety and Mood: Endpoint Comparison

This table maps where each peptide's published research actually concentrates, so a protocol gets built around evidence rather than reputation. Read the bottom-line column before the other two.

Endpoint	Semax in the literature	Selank in the literature	Bottom Line
Memory and learning	Rodent retention tasks plus Russian human data in cognitive impairment; BDNF and TrkB upregulation is the proposed driver	Some rodent learning data exists, but cognition is a secondary theme rather than the focus	Semax is the better-supported choice for memory-focused research designs
Anxiety	Limited direct anxiolytic data; not the primary research lane	Central research focus, including comparisons against benzodiazepines without reported sedation or withdrawal	Selank is the anxiolytic candidate; Semax is not a substitute here
Attention and ADHD models	Russian paediatric attention-deficit literature exists but is small and not replicated in Western trials	Studied mainly in asthenic and anxious-asthenic presentations rather than attention deficits	Both are preliminary; Semax has the closer-matched literature, neither has RCT support
Depression and mood	BDNF-linked neurotrophic effects explored as an adjunct in asthenic-depressive states	Serotonin turnover and cytokine modulation explored in comorbid anxiety-depression presentations	Neither functions as an antidepressant; mood data is adjunctive at best
Sleep	Generally described as activating, not sedating	Sleep improvement reported as downstream of reduced anxiety, not a direct hypnotic effect	Selank has the more plausible sleep-adjacent rationale, through anxiety reduction only
Energy and drive	Dopaminergic and catecholaminergic modulation underpins reports of increased alertness	Broadly neutral to calming; not an energy-endpoint compound	Semax is the energy-adjacent candidate of the two

What If: Laboratory Scenarios With Semax and Selank

What if the lyophilized cake is collapsed or shifted inside the vial?

Document it, then check the batch certificate before assuming a problem. Cake collapse frequently reflects vacuum variation or transit vibration rather than degradation, and a shifted plug can still assay at full purity. What matters is whether the seal held. Any vial with a compromised stopper should be quarantined rather than reconstituted into an experiment.

What if the powder sat above refrigeration temperature in transit?

Treat it as a data-integrity question, not a discard-or-keep coin flip. Lyophilized heptapeptides tolerate short ambient excursions far better than solutions do, because water is what enables hydrolysis and aggregation. A reconstituted vial exposed above 8°C is a different case entirely, and no home or bench inspection can detect the resulting loss of peptide integrity.

What if a cognition assay shows no measurable effect in the first cohort?

Check delivery route and degradation before touching the hypothesis. Both peptides are cleaved rapidly by peptidases, which is precisely why the original Russian work used intranasal administration and why amidated analogs were developed. Null results in short-half-life peptide research more often trace to compound residence time or handling than to absent pharmacology.

What if a design needs both compounds in the same study?

Build in a Pro-Gly-Pro arm. Because both peptides degrade toward the same glyproline fragment, a combined design without that control cannot cleanly attribute any shared outcome to either parent molecule. This is the single most common structural weakness we see in comparative protocols submitted by newer labs.

The uncomfortable truth about ranking these two peptides

Let's be direct about this: most of what circulates online about semax vs selank for memory is a restatement of a small, mostly Russian evidence base that has never cleared a Western Phase 3 trial. The mechanistic work on BDNF, GABAergic signalling and enkephalin turnover is real and interesting. The human clinical data is thin, frequently open-label, and rarely large. Anyone presenting these compounds as settled cognitive enhancers is overselling the record badly. Research-grade purity and honest evidence framing matter more here than any confident ranking, which is why every batch we release publishes a certificate of analysis.

Researchers comparing semax vs selank for memory and anxiety endpoints usually cross-reference both compound backgrounders before ordering, so the reference pages for Semax and Selank sit alongside the Semax liquid spray and Selank liquid spray listings. Labs running attention, mood or sleep models also work through the focus and cognition collection and the sleep support collection, with the full catalog and facility details available for procurement records.

The semax vs selank for memory debate keeps getting framed as a contest, when the literature reads more like two research programmes that barely overlap. One followed a hormone fragment into neurotrophic and cognitive territory. The other followed an immune peptide into stress and anxiety physiology. They met in the middle only because both needed the same stabilizing tail to survive contact with peptidases. Judge them by which body of evidence answers your question, and the choice usually makes itself before the first vial is reconstituted.

References

Peer-reviewed sources on Selank indexed in PubMed, listed for research context. Real Peptides supplies Selank for laboratory research use only.

Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats. Bulletin of experimental biology and medicine, 2022. PMID 36322304. doi:10.1007/s10517-022-05624-x
The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress. Current reviews in clinical and experimental pharmacology, 2021. PMID 32621722. doi:10.2174/1574884715666200704152810
Functional Connectomic Approach to Studying Selank and Semax Effects. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2020. PMID 32342318. doi:10.1134/S001249662001007X
Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank. Bulletin of experimental biology and medicine, 2020. PMID 32651826. doi:10.1007/s10517-020-04868-9
Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bulletin of experimental biology and medicine, 2019. PMID 31625062. doi:10.1007/s10517-019-04588-9
Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress. Bulletin of experimental biology and medicine, 2019. PMID 31243679. doi:10.1007/s10517-019-04512-1
Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein and peptide letters, 2018. PMID 30255741. doi:10.2174/0929866525666180925144642
Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Restraint Stress. Bulletin of experimental biology and medicine, 2017. PMID 28853100. doi:10.1007/s10517-017-3817-8

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Selank carries the stronger anxiolytic research record. Russian clinical studies describe it in generalized anxiety and adjustment-type presentations, reportedly without sedation, muscle relaxation or withdrawal effects. Semax research focuses on cognition and neuroprotection instead. Neither is FDA-approved, and both are supplied strictly as research-use-only compounds for laboratory investigation.

Evidence is preliminary and geographically narrow. Russian paediatric literature describes Semax in attention deficit and minimal brain dysfunction contexts, while Selank appears mainly in asthenic and anxious-asthenic states. No Western randomized controlled trials support either compound in ADHD, so any attention-related finding should be treated as exploratory research rather than established pharmacology.

Sleep is not a primary endpoint for either peptide. Where Selank research reports improved sleep, it appears downstream of reduced anxiety rather than through any direct hypnotic mechanism. Semax is consistently characterized as activating rather than sedating. Neither compound is studied as a sleep agent, and neither is approved for any use.

Semax, an ACTH(4-10) analog, is associated with upregulation of BDNF and its TrkB receptor in the hippocampus and cortex, plus dopaminergic and serotonergic modulation. Selank, a tuftsin analog, acts more on GABAergic signalling, serotonin turnover and cytokine expression including interleukin-6. The neurotrophic pathway is why Semax dominates cognition research.

In research terms, Semax has the closer-matched literature because its documented endpoints include attention, working memory and mental performance under load. Selank's relevance to study-type tasks would be indirect, through anxiety reduction. Neither compound is approved or intended for human use, and no Western trial has evaluated either for academic performance.

Semax is the energy-adjacent compound of the two. Its dopaminergic and catecholaminergic modulation underlies descriptions of increased alertness and activation in the literature, while Selank is broadly neutral to calming. Researchers investigating fatigue or cellular energy endpoints often pair Semax work with mitochondrial-focused compounds rather than with Selank.

Combined designs appear in some Russian literature, but they carry a specific methodological trap. Both peptides degrade toward the same Pro-Gly-Pro glyproline, which is biologically active on its own, so any shared outcome cannot be cleanly attributed without a Pro-Gly-Pro control arm in the design.

No. Neither peptide is FDA-approved for any indication in the United States. Both were developed and registered in Russia and remain research-use-only compounds elsewhere. They are supplied for laboratory investigation only and are not intended for human or veterinary consumption under any circumstances.

Pricing varies widely by format, quantity and purity verification, with liquid spray presentations and amidated analogs typically priced differently from standard lyophilized vials. Rather than quoting a single figure, compare listings alongside the published certificate of analysis for each batch, since verified purity is the variable that actually determines value.

Lyophilized peptide is held at -20°C, and reconstituted solution is refrigerated at 2 to 8°C. Repeated freeze-thaw cycling is the most common cause of silent potency loss, because degradation and aggregation produce no visible change in the vial. Storage records matter as much as the storage itself for data integrity.

It lacks scale, blinding consistency and independent replication. Most supporting human data comes from small domestic Russian studies, frequently open-label, with endpoints and reporting standards that differ from those required in Western Phase 3 programmes. The mechanistic rodent work is far more robust than the clinical record built on top of it.

The amidated and acetylated analog was engineered to resist aminopeptidase cleavage at the terminal ends, extending how long intact peptide persists after administration. Standard Semax degrades quickly in plasma, which is why the original clinical work relied on intranasal delivery. Both remain research-use-only, with no approved human application.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA